-
1دورية أكاديمية
المؤلفون: Nicholas James, Sarah Pirrie, Ann Pope, Darren Barton, Lazaros Andronis, Ilias Goranitis, Stuart Collins, Duncan McLaren, Joe O’Sullivan, Chris Parker, Emilio Porfiri, John Staffurth, Andrew Stanley, James Wylie, Sharon Beesley, Alison Birtle, Janet Brown, Prabir Chakraborti, Martin Russell, Lucinda Billingham
المصدر: Health Technology Assessment, Vol 20, Iss 53 (2016)
مصطلحات موضوعية: trapeze, zoledronic acid, strontium-89, bony metastatic castrate refractory prostate cancer, prostate cancer, randomised trial, Medical technology, R855-855.5
وصف الملف: electronic resource
-
2
المؤلفون: Janet E Brown, Kara-Louise Royle, Walter Gregory, Christy Ralph, Anthony Maraveyas, Omar Din, Timothy Eisen, Paul Nathan, Tom Powles, Richard Griffiths, Robert Jones, Naveen Vasudev, Matthew Wheater, Abdel Hamid, Tom Waddell, Rhona McMenemin, Poulam Patel, James Larkin, Guy Faust, Adam Martin, Jayne Swain, Janine Bestall, Christopher McCabe, David Meads, Vicky Goh, Tze Min Wah, Julia Brown, Jenny Hewison, Peter Selby, Fiona Collinson, Judith Carser, Gopalakrishnan Srinivasan, Fiona Thistlewaite, Ashraf Azzabi, Mark Beresford, David Farrugia, Marios Decatris, Carys Thomas, Joanna Gale, James McAleer, Alison Clayton, Ekaterini Boleti, Thomas Geldart, Santhanam Sundar, Jason Lester, Nachi Palaniappan, Mohan Hingorani, Khaliq Rehman, Mohammad Khan, Naveed Sarwar, Janine Graham, Alastair Thomson, Narayanan Srihari, Denise Sheehan, Rajaguru Srinivasan, Omar Khan, Andrew Stockdale Jane Worlding, Stergios Boussios, Nicholas Stuart, Carey MacDonald-Smith, Falalu Danwata, Duncan McLaren, Aravindhan Sundaramurthy, Anna Lydon, Sharon Beesley, Kathryn Lees, Mohini Varughese, Emma Gray, Angela Scott, Mark Baxter, Anna Mullard, Pasquale Innominato, Gaurav Kapur, Anil Kumar, Natalie Charnley, Caroline Manetta, Prabir Chakraborti, Prantik Das, Sarah Rudman, Henry Taylor, Christos Mikropoulos, Martin Highley, Dakshinamoorthy Muthukumar, Anjali Zarkar, Roy Vergis, Seshadri Sriprasad, Patryk Brulinski, Amanda Clarke, Richard Osbourne, Melanie Harvey, Renata Dega, Geoffrey Sparrow, Urmila Barthakur, Erica Beaumont, Agnieszka Michael, Emilio Porfiri, Faisal Azam, Ravi Kodavtiganti
المصدر: STAR Investigators, Brown, J E, Royle, K-L, Gregory, W, Ralph, C, Maraveyas, A, Din, O, Eisen, T, Nathan, P, Powles, T, Griffiths, R, Jones, R, Vasudev, N, Wheater, M, Hamid, A, Waddell, T, McMenemin, R, Patel, P, Larkin, J, Faust, G, Martin, A, Swain, J, Bestall, J, McCabe, C, Meads, D, Goh, V, Min Wah, T, Brown, J, Hewison, J, Selby, P & Collinson, F 2023, ' Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial ', Lancet Oncology, vol. 24, no. 3, pp. 213-227 . https://doi.org/10.1016/S1470-2045(22)00793-8
مصطلحات موضوعية: SDG 3 - Good Health and Well-being, Oncology
وصف الملف: application/pdf
-
3
المؤلفون: Frcr John McGrane, Hilary Glen, Frcr Chinnamani Eswar, Frcr Mark Beresford, Frcr Mohini Varughese, Serena Hilman, Deborah Enting, Frcr Maria Vilarino-Varela, Anand Sharma, Ananya Choudhury, Vincent Khoo, Frcr Caroline Manetta, Naveen S. Vasudev, Frcr Daniel R. Henderson, Frcr Darren Mitchell, Alastair Law, Robert Huddart, Frcr Sharon Beesley, Jun Hao Lim, Frcr Sarah Treece, Simon J. Crabb, Shaista Hafeez, Elias Pintus, Frcr Darren Leaning, Caroline Chau, Frcr Yvonne Rimmer, Frcs Rajagopalan Sriram
المصدر: International Journal of Radiation Oncology*Biology*Physics. 110:1143-1150
مصطلحات موضوعية: Adult, Male, Cancer Research, Poor prognosis, medicine.medical_specialty, medicine.medical_treatment, Treatment outcome, Patient characteristics, Disease, Small-cell carcinoma, Disease-Free Survival, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Carcinoma, Small Cell, Aged, Neoplasm Staging, Retrospective Studies, Chemotherapy, Radiation, business.industry, Hazard ratio, Retrospective cohort study, Middle Aged, medicine.disease, United Kingdom, Treatment Outcome, Urinary Bladder Neoplasms, Oncology, 030220 oncology & carcinogenesis, business
وصف الملف: text
-
4
المؤلفون: Helen Teixeira, Myungkuk Kang, Kathryn Lees, Albert Edwards, Alastair Henderson, Sharon Beesley
المصدر: Journal of Clinical Urology. 12:353-360
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, Brachytherapy, Treatment options, Newly diagnosed, medicine.disease, Multidisciplinary team, Prostate cancer, medicine, Surgery, Medical physics, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4de7be09ec4532b1da82621d7b6ec734
https://doi.org/10.1177/2051415819841703 -
5
المؤلفون: B. Ayres, Kelechi Njoku, Ian Eardley, Perric Crellin, Sharon Beesley, Lisa Pickering, Mehran Afshar, Mamoun Elmamoun, Lona Vyas, Angus Roninson, Oliver Kayes, Maria Serra, Ann Henry, Alison Tree, Nick Watkin, Michael Ager
المصدر: Journal of Urology. 201
مصطلحات موضوعية: endocrine system, Adjuvant radiotherapy, medicine.medical_specialty, genetic structures, business.industry, Urology, 030232 urology & nephrology, 03 medical and health sciences, 0302 clinical medicine, medicine.anatomical_structure, medicine, Basal cell, Radiology, business, Penis
-
6
المؤلفون: Janet E. Brown, J.M. Russell, Hassan Douis, Adrian Cook, Matthew R. Sydes, David Matheson, Narayanan Srihari, Alex Hoyle, Matthew S. Simms, A. Nikapota, Anjali Zarkar, Christopher D. Brawley, F.C. Ingleby, Noel W. Clarke, J. Calvert, John Wagstaff, Duncan C. Gilbert, Gerhardt Attard, Jacob Tanguay, A.W.S. Ritchie, Adnan Ali, Ruth E Langley, Andrew Protheroe, Aurelius Omlin, H. Rush, Anna Lydon, David P. Dearnaley, Malcolm David Mason, James D. Wylie, Silke Gillessen, Simon Chowdhury, L. Capaldi, Sharon Beesley, Joe M O'Sullivan, Mona Parmar, Omi Parikh, Joanna Gale, Jan Wallace, S. Rudman, Chris Parker, Alison Birtle, Archie Macnair, Claire Amos, Stephanie Gibbs, Robin Millman, Robert Jones, Zafar Malik, William Cross, Nicholas D. James, Shaun Tolan
المصدر: STAMPEDE Investigators 2019, ' Addition of docetaxel to hormonal therapy in low-and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial ', Annals of Oncology . https://doi.org/10.1093/annonc/mdz396
Annals of Oncologyمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Androgen deprivation therapy, 03 medical and health sciences, Prostate cancer, STAMPEDE trial, 0302 clinical medicine, Urogenital Tumors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, hormone naive, medicine, Humans, docetaxel, Progression-free survival, Neoplasm Metastasis, Disease burden, Aged, Proportional Hazards Models, Retrospective Studies, Manchester Cancer Research Centre, business.industry, Proportional hazards model, ResearchInstitutes_Networks_Beacons/mcrc, Prostatic Neoplasms, Androgen Antagonists, Retrospective cohort study, Hematology, Original Articles, Middle Aged, medicine.disease, prostate cancer, Progression-Free Survival, metastatic, 030104 developmental biology, Docetaxel, randomised control trial, 030220 oncology & carcinogenesis, Disease Progression, Hormonal therapy, business, medicine.drug
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae50219cab2735395675e6bd870c6e64
https://doi.org/10.1093/annonc/mdz396 -
7
المؤلفون: Duncan C. Gilbert, Joanna Gale, Nicholas D. James, Shaun Tolan, Claire Amos, Robin Millman, Zafar Malik, G. Attard, James D. Wylie, Anjali Zarkar, S. Rudman, Robert Jones, Anna Lydon, Noel W. Clarke, Chris Parker, Joe M O'Sullivan, Jan Wallace, Aurelius Omlin, Alison Birtle, Adrian Cook, Archie Macnair, Malcolm David Mason, A.W.S. Ritchie, Matthew S. Simms, Alex Hoyle, Adnan Ali, H. Rush, John Wagstaff, Christopher D. Brawley, Jacob Tanguay, Andrew Protheroe, Silke Gillessen, Ruth E Langley, F.C. Ingleby, Omi Parikh, Stephanie Gibbs, David P. Dearnaley, David Matheson, Matthew R. Sydes, William Cross, Simon Chowdhury, L. Capaldi, Sharon Beesley, J. Calvert, Janet E. Brown, J.M. Russell, Hassan Douis, Narayanan Srihari, A. Nikapota, Mona Parmar, Stampede Investigators
المصدر: Annals of Oncology. 31:442
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, MEDLINE, Hematology, Hormone sensitive prostate cancer, Docetaxel, Internal medicine, Long term survival, medicine, Hormonal therapy, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::47b985e6be9b562abd6b7317e5eed22c
https://doi.org/10.1016/j.annonc.2020.01.002 -
8
المؤلفون: Michael Ager, Mehran Afshar, Kelechi Njoku, Angus Robinson, Mamoun Elmamoun, Sharon Beesley, Lona Vyas, Lisa Pickering, Maria Serra, Nick Watkin, Oliver Kayes, Ann Henry, Ian Eardley, Alison Tree, Benjamin Ayres, Perric Crellin
المصدر: Clinical Oncology. 31:e12
مصطلحات موضوعية: Adjuvant radiotherapy, medicine.medical_specialty, medicine.anatomical_structure, Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Basal cell, Radiology, business, Penis
-
9
المؤلفون: Prabir Chakraborti, James D. Wylie, Ann Pope, Ilias Goranitis, Andrew Stanley, Emilio Porfiri, Duncan McLaren, Adam Daunton, Nicholas D. James, Lucinda Billingham, J. Martin Russell, Alison Birtle, Lazaros Andronis, Sharon Beesley, Chris Parker, Darren Barton, Joe M. O'Sullivan, Sarah Pirrie, John Staffurth, Janet E. Brown, Syed A. Hussain, Stuart Collins
المصدر: Andronis, L, Goranitis, I, Pirrie, S, Pope, A, Barton, D, Collins, S, Daunton, A, McLaren, D, O'Sullivan, J M, Parker, C, Porfiri, E, Staffurth, J, Stanley, A, Wylie, J, Beesley, S, Birtle, A, Brown, J E, Chakraborti, P, Hussain, S A, Russell, J M, Billingham, L J & James, N D 2017, ' Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer : results from the TRAPEZE trial (ISRCTN 12808747) ', BJU International, vol. 119, no. 4, pp. 522-529 . https://doi.org/10.1111/bju.13549
Andronis, L, Goranitis, I, Pirrie, S, Pope, A, Barton, D, Collins, S, Daunton, A, McLaren, D, O'Sullivan, J M, Parker, C, Porfiri, E, Staffurth, J, Stanley, A, Wylie, J, Beesley, S, Birtle, A, Brown, J E, Chakraborti, P, Hussain, S A, Russell, J M, Billingham, L J & James, N D 2016, ' Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747) ', BJU International . https://doi.org/10.1111/bju.13549مصطلحات موضوعية: Oncology, Male, Cost effectiveness, Cost-Benefit Analysis, Zoledronic Acid, law.invention, zoledronic acid, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Medicine, 030212 general & internal medicine, Prospective Studies, Prospective cohort study, health care economics and organizations, Bone Density Conservation Agents, Diphosphonates, 030503 health policy & services, Imidazoles, cost-effectiveness analysis, Cost-effectiveness analysis, Sr89, Prostatic Neoplasms, Castration-Resistant, Docetaxel, 0305 other medical science, medicine.drug, bone protecting treatments, medicine.medical_specialty, Urology, Bone Neoplasms, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Humans, business.industry, R1, United Kingdom, Surgery, Clinical trial, Zoledronic acid, quality of life, Strontium, Concomitant, Quality of Life, Radiopharmaceuticals, business, castrate-refractory prostate cancer
وصف الملف: application/pdf
-
10
المؤلفون: Andrew Stanley, Alison Birtle, Sarah Pirrie, Lucinda Billingham, Nicholas D. James, John Staffurth, Janet E. Brown, Joe M. O'Sullivan, Stuart Collins, Sharon Beesley, Martin J. Russell, James D. Wylie, Emilio Porfiri, Chris Parker, Darren Barton, Duncan McLaren, Lazaros Andronis, Prabir Chakraborti, Ann Pope, Ilias Goranitis
المصدر: Health Technology Assessment, Vol 20, Iss 53 (2016)
James, N, Pirrie, S, Pope, A, Barton, D, Andronis, L, Goranitis, I, Collins, S, McLaren, D, O'Sullivan, J, Parker, C, Porfiri, E, Staffurth, J, Stanley, A, Wylie, J, Beesley, S, Birtle, A, Brown, J, Chakraborti, P, Russell, M & Billingham, L 2016, ' TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer ', Health Technology Assessment, vol. 20, no. 53, pp. 1-288 . https://doi.org/10.3310/hta20530مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, lcsh:Medical technology, Cost effectiveness, Cost-Benefit Analysis, Prednisolone, Antineoplastic Agents, Bone Neoplasms, Docetaxel, Zoledronic Acid, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Maintenance therapy, Randomized controlled trial, law, Internal medicine, Journal Article, medicine, Humans, 030212 general & internal medicine, Aged, Bone Density Conservation Agents, Diphosphonates, business.industry, Health Policy, Hazard ratio, Imidazoles, Middle Aged, R1, Quality-adjusted life year, Surgery, Clinical trial, Prostatic Neoplasms, Castration-Resistant, Zoledronic acid, lcsh:R855-855.5, 030220 oncology & carcinogenesis, Quality of Life, Strontium Radioisotopes, Taxoids, Quality-Adjusted Life Years, business, Research Article, medicine.drug
وصف الملف: application/pdf; application/x-pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c447bab25d37f48bed8674ed525bf403
https://doaj.org/article/c615d29188e14af3b091335974572196